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Exist controversy about the interference of the caffeine 
in the vestibular test. Coffee is the richest source of caffeine. 
While in some services, the patients were orient to suspend 
the ingestion of caffeine 24 to 48 hours before the vestibular 
test, other not consider the suspension of this drink necessary. 
Aim: To evaluate the effect of caffeine in the vestibular test 
result. Study design: clinical with transversal cohort. Material 
and Method: Seccional and matched research. The vestibular 
test was performed twice in the same patient, with five days 
interval between the exams. In the first test, the patient did 
not drink coffee 24 hours before the exam; in the second, 
the patient drunk coffee as usual. All of the participants 
had clinical indication for vestibular test and were used to 
drinking coffee. Results: Nineteen women, medium age of 
49,5 years, participated. The average coffee consumption was 
three cups per day. The complaints of anxiety and headache 
were associated with the submission to the vestibular test 
without coffee. The exams were not statistically different 
comparing the results of the tests performed with and without 
the coffee ingestion. Conclusion: The moderate ingestion 
of coffee was not shown to interfere in the results of the 
vestibular test. Considering that it is recommended that 
the patient be calm to be submitted to the vestibular test 
and that the half-life of the caffeine is only of six hours, 
we suggest that the orientation of complete and abrupt 
drinking coffee suspension of moderate dose before the 
vestibular test for the individuals used to daily drinking 
coffee be reevaluated.
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INTRODUCTION
Caffeine is the most used psychoactive substance 
in the world1. About 80% of the general population uses 
this substance daily, be it through coffee, tea, chocolate, 
soft drinks or caffeine-based drugs. Coffee is the richest 
source of caffeine2. After oral intake, caffeine is quickly 
eliminated with a half-life of four to six hours3.
The moderate intake of coffee is defined as daily 
intake that ranges from 200 to 300 milligrams2. Excessive 
intake is defined above 600 mg/day4. One cup of Brazilian 
coffee (60ml) normally has 50.4 mg caffeine2, and accord-
ing to the authors it may vary from 85 mg to 125 mg5.
Under experimental conditions, caffeine, in mod-
erate doses, produces excellent physical and intellectual 
performance, increase in concentration and reduction in 
time of response to sensorial stimuli6. Conversely, high 
doses may cause perceptible signs of mental confusion 
and induction of mistakes in intellectual tasks, anxiety, 
nervousness, muscle tremors, tachycardia and tinnitus3,6. 
Sudden interruption of caffeine intake may lead to with-
drawal syndrome. The most common symptoms are fa-
tigue, anxiety and depression, nausea, vomiting, headache 
and reduced concentration7,8. The occurrence of anxiety 
with sudden suspension of caffeine may be present even 
in subjects that take low doses of the substance (50 to 
150 mg/day)9.
Instructions about coffee intake interruption before 
vestibular tests vary from service to service. Some authors 
recommend that the patients interrupt coffee intake 72 
hours before the test10,11. Others indicate interruption for 
48 hours12,13 or for 24 hours14,15. There are those that recom-
mend no intake on the exam day16,17 and other that make 
no restrictions to intake18-20.
It is essential to maintain the patient calm during 
the performance of the vestibular test because stress and 
anxiety may lead to changes in tracing, especially caloric 
hyperreflexia21,22, inducing the mistaken diagnosis of ves-
tibular disease18. The present study aims at assessing the 
effect of moderate doses of coffee in the vestibular test.
METHODS
The present study was a comparative, transversal, 
matched analysis in which the studied group comprised 
patients that had taken caffeine, according to their own 
habits, and the control group was the same patients with-
out the use of the substance. Considering that among the 
foods that contain caffeine coffee is the one that con-
tributes the most to its intake2, researchers defined the 
concentration of caffeine based on daily coffee intake of 
participants.
The study comprised subjects sent from different 
primary care centers in Belo Horizonte with otorhinolaryn-
gologists’ referral to perform vestibular test.
Nineteen patients with vestibular symptoms that 
used to drink coffee everyday were enrolled in the study. 
None of them had been previously submitted to the test 
or had clinical presentation compatible with central laby-
rinth pathology.
First, patients were submitted to vestibular test fol-
lowing the instruction provided by the Service of Audiol-
ogy, Hospital das Clínicas, Medical School, UFMG, which 
were: interruption of non-essential drugs and alcoholic 
drinks for 72 hours before the test; cigarette and caffeine 
(coffee, chocolate, soft drinks) for 24 hours before the 
test, and fasting for 3 hours before the test. Next, the 
same subjects underwent the vestibular test a second time, 
but a different examiner performed it the second time. 
Vestibular tests were performed by different examiners 
so that patients were not used to it in the second time. 
Thus, patients were alert in both tests. Examiners were 
previously trained so that the first and second tests were 
exactly the same.
The instructions were the same, except for no inter-
ruption of caffeine intake in the second test.
Vectoelectronystagmography was the method used 
to record ocular movements, applying the triangular place-
ment of electrodes 23. We used the equipment brand 
Contronic do Brasil version5. The assessment of balance 
comprised the following steps: clinical examination with 
Frenzel lenses, ocular motricity test and caloric test. We 
assessed saccadic oculomotor movement, tracking and 
optokinetic movements, in addition to spontaneous and 
semi-spontaneous nystagmus. Vestibular assessment 
included caloric test in temperatures of 30°C and 44°C 
with water. Data generated for the study were analyzed 
using the statistical program EPI-INFO 6.04. For the statis-
tical comparison, we applied McNemar test for matched 
analysis. The level of statistical significance for the study 
was 5%.
The project and the consent forms were analyzed 
and approved by the Research Ethics Committee, Federal 
University of Minas Gerais. All involved subjects agreed to 
participate in the study and in the dissemination of results, 
in compliance with Resolution nº196 of 1996.
RESULTS
The mean age of participants was 49.5 years, rang-
ing from 21 to 76 years. All subjects were female patients. 
Mean daily consumption of coffee in the studied popula-
tion was three cups (Table 1).
The assessment of the most frequent clinical symp-
toms in relation to vestibular test, with and without coffee 
intake, are presented in Graph 1. Three patients did not 
respond to the questionnaire. The highest prevalence of 
headache and anxiety occurred in patients submitted to 
the vestibular test with suspension of coffee (p=0.01).
Considering the choice of the patient, 13 (68.4%) 
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preferred to be submitted to the vestibular test with 
habitual coffee intake. Among the 13 patients, the com-
plaints related with sudden suspension of the drink were 
anxiety (92.3%), headache (69.3%), nausea and vomiting 
(38.5%), and more marked vertigo during the test (38.5%). 
Graph 2 demonstrated that the frequency of withdrawal 
syndrome has increased with daily dose of caffeine in 
those patients.
In the result of the vestibular test, no abnormality 
was observed concerning calibration or measurement 
of the oculomotor movements with and without coffee 
suspension. As to caloric test, there was no statistically 
significant difference between the results found with and 
without coffee, considering as normal the number of 
labyrinthic predominance and directional predominance 
of the nystagmus up to 33%. The matched analysis of data 
referring to caloric test is demonstrated in Table 2.
DISCUSSION
In agreement with previous studies, dizziness is 
the most frequent complaint in female gender and it 
predominates in the 5th and 6th decades of life in both 
genders19,24.
The preference of the vestibular test performed 
with habitual coffee intake (68.4%) may be justified by 
the higher occurrence of anxiety and headache associated 
with the test when the instruction to interrupt the intake 
of caffeine was given (p=0.01).
Caffeine withdrawal syndrome may occur after sud-
den interruption of intake in those used to moderate or 
low doses of caffeine20, 21. In this study, most participants 
were used to take daily moderate doses of caffeine (three 
cups a day)2. The complaints of anxiety and headache 
increased as a result of increased doses of caffeine intake. 
Table 1. Average consumption of caffeine in patients with 
complaints of dizziness. N=19. Sector of Audiology, Hospital 
das Clínicas, UFMG —Belo Horizonte, 2004.
 Number 1\1g/day Number of 
 of cups  patients (%)
 2 100 a 200mgl/day 5 (26,3%)
 3 150 a 300mgl/day 6 (31,6%)
 4 200 a400mgl/day 8 (42,1%)
Table 2. Comparative analysis of results of the calculation of 
post-caloric nystagmus with and without coffee suspension. 
N=17. Sector of Audiology, Hospital das Clínicas, UFMG —Belo 
Horizonte, 2004.
Prova Cabrita
 Caloric W/out coffee With coffee TOTAL 
 test suspension suspension
 Normal 14 14 28
 Abnormal 3 3 6
 TOTAL 17 17 34
P value (Mc Nemar) > 0.05.
Graph 1. Comparative distribution of complaints in the vestibular test 
with and without coffee intake. N=16. Sector of Audiology, Hospital 
das Clínicas, UFMG —Belo Horizonte, 2004.
Graph 2. Distribution of symptoms associated with the vestibular test 
without coffee intake in relation to number of coffee cups taken per 
day. N=13. Sector of Audiology, Hospital das Clínicas, UFMG — Belo 
Horizonte, 2004.
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Thus, these symptoms present in the test after previous 
interruption of coffee intake could be manifestations of 
caffeine withdrawal syndrome, which could negatively 
interfere in the results of the vestibular test. Anxiety can 
cause changes to the tracing of vectoelectronystagmogra-
phy, leading to misdiagnosis of vestibular disease18.
The vestibular test is a type of test that may gener-
ate some uneasiness in the patient. In the present study, 
the test with instructions to interrupt coffee intake was the 
first one to be performed. Thus, anxiety could have been 
associated with two factors: 1) fear of the exam; 2) caffeine 
withdrawal syndrome. The highest frequency of headache 
in the test with previous interruption of caffeine intake, 
conversely, would not be justified by lack of knowledge 
about the test. It is interesting to notice that headache is an 
important symptom in caffeine withdrawal syndrome12.
The pharmacological actions of caffeine are well 
known. In moderate doses, it maintains the subject alert, 
with greater and more constant intellectual activity, favor-
ing complex association of ideas and reducing the time of 
reaction to sensorial stimuli6. The improvement in the proc-
ess of vestibular compensation has been demonstrated25-27. 
In high doses, caffeine is toxic to the vestibular system. 
It may cause impairment of the systems of convergence 
and accommodation, reduction in saccadic movements 
and peripheral vestibular dysfunction28.
The influence of psychological factors during the 
performance of a vestibular test has been considered in 
the quality of the test. To maintain the patient relaxed, and 
at the same time alert, is essential for the success of the 
exam. In this study, the result of the vestibular test was 
similar with and without coffee intake. Therefore, inter-
ruption of low and moderate doses of caffeine before the 
vestibular test should be reassessed, given that in subjects 
used to take such drinks daily the interruption may trigger 
undesirable anxiety reactions in subjects that are going to 
be submitted to the vestibular test.
CONCLUSION
In the present study, the results of the vestibular test 
after the intake of moderate doses of coffee were similar 
to the results with suspension of coffee intake up to 24 
hours before the test. Interruption proved to be unneces-
sary. As to coffee intake instruction before the vestibular 
test, moderate intake (up to 3 cups/ 24 hours) may be 
allowed, with restriction for the last intake up to 6 hours 
before the test (caffeine half-life).
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